131 related articles for article (PubMed ID: 30276134)
1. Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells.
Majidi Zolbanin N; Jafari R; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Nayebi AM
Adv Pharm Bull; 2018 Aug; 8(3):383-393. PubMed ID: 30276134
[No Abstract] [Full Text] [Related]
2. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
4. Aptamer decorated hyaluronan/chitosan nanoparticles for targeted delivery of 5-fluorouracil to MUC1 overexpressing adenocarcinomas.
Ghasemi Z; Dinarvand R; Mottaghitalab F; Esfandyari-Manesh M; Sayari E; Atyabi F
Carbohydr Polym; 2015 May; 121():190-8. PubMed ID: 25659689
[TBL] [Abstract][Full Text] [Related]
5. Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells.
Khorshid M; Varshosaz J; Rostami M; Haghiralsadat F; Akbari V; Khorshid P
Biomater Adv; 2023 Nov; 154():213591. PubMed ID: 37611441
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-Chitosan nanoparticles for breast cancer treatment: cell viability and gene expression study.
Mirzaie ZH; Irani S; Mirfakhraie R; Atyabi SM; Dinarvand M; Dinarvand R; Varshochian R; Atyabi F
Chem Biol Drug Des; 2016 Dec; 88(6):850-858. PubMed ID: 27390258
[TBL] [Abstract][Full Text] [Related]
7. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells.
Varshosaz J; Davoudi MA; Rasoul-Amini S
J Liposome Res; 2018 Dec; 28(4):285-295. PubMed ID: 28826287
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies.
Jain A; Thakur K; Kush P; Jain UK
Int J Biol Macromol; 2014 Aug; 69():546-53. PubMed ID: 24971551
[TBL] [Abstract][Full Text] [Related]
10. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
11. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs.
Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Najafi R
Colloids Surf B Biointerfaces; 2022 Oct; 218():112714. PubMed ID: 35905589
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
Abozeid SM; Hathout RM; Abou-Aisha K
Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
[TBL] [Abstract][Full Text] [Related]
14. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
15. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Kumar Mehata A; Bharti S; Singh P; Viswanadh MK; Kumari L; Agrawal P; Singh S; Koch B; Muthu MS
Colloids Surf B Biointerfaces; 2019 Jan; 173():366-377. PubMed ID: 30316083
[TBL] [Abstract][Full Text] [Related]
19. Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line.
Siahmansouri H; Somi MH; Babaloo Z; Baradaran B; Jadidi-Niaragh F; Atyabi F; Mohammadi H; Ahmadi M; Yousefi M
J Pharm Pharmacol; 2016 Sep; 68(9):1119-30. PubMed ID: 27350211
[TBL] [Abstract][Full Text] [Related]
20. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
Liu L; Li H; Zhang M; Lv X
Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]